This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Timothy Pang
Executive Director at Citeline


  • Timothy joined the Citeline Custom Intelligence team in London in 2012, and has over 20 years’ experience in the pharmaceutical industry. Prior to joining Citeline, Timothy worked in a managerial role for a Japanese pharmaceutical company based in Tokyo, where he helped plan and lead the development of product candidates in therapy areas including oncology supportive care, migraine, and pain. Timothy led product positioning and market analysis for the product portfolio, while also collaborating on partnership and licensing activities for the US and other markets.
  • Earlier in his career, Timothy worked as a Senior Analyst within Datamonitor Healthcare’s London based analysis team, focusing on immune and inflammatory disorders, including diseases in the gastroenterology, respirology, rheumatology, immunology, and dermatology therapy areas. Timothy transferred to Datamonitor Healthcare’s Tokyo office in 2005, where he established that office’s first consulting/analysis presence. Prior to Datamonitor Healthcare, Timothy began his career at the World Markets Research Centre (later part of IHS Markit), where he authored analysis on the Asian pharmaceutical and healthcare industries, focusing on Greater China and Japan.
  • While based in Tokyo for 6.5 years, Timothy spent approximately 1 year in the US, gaining experience in areas including pricing and reimbursement, regulatory affairs, and health economics. •Timothy holds a Master’s in Public Health, with a concentration in health economics and pharmacoeconomic modeling. His Master’s dissertation was an economic analysis from the health systems perspective of the launch of a vaccine into a national immunization program.
  • Timothy wrote the chapter on LCM strategies and tactics in the recently published book Global Pharmaceutical and Biologics Regulatory Strategy, with a foreword by former FDA Commissioner Margaret Hamburg.
  • Timothy holds an MSc (Public Health) from the London School of Hygiene and Tropical Medicine (University of London), and an MA (Sinology) from the School of Oriental and African Studies (University of London).
  • Timothy is fluent in English, Mandarin, and Japanese.

Agenda Sessions

  • APAC partnering: where are we and where does the future lie?